Rhenman & Partners Asset Management AB Decreases Stake in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)

Rhenman & Partners Asset Management AB decreased its holdings in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 16.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 37,500 shares of the biopharmaceutical company’s stock after selling 7,500 […]

Related Keywords

Wellington ,New Zealand General ,New Zealand ,London ,City Of ,United Kingdom ,William Blair ,Amyw Schulman ,Wellington Management Group ,News Ratings For Alnylam Pharmaceuticals Daily ,Quarter For Alnylam Pharmaceuticals ,Royal London Asset Management Ltd ,Cantor Fitzgerald ,Alnylam Pharmaceuticals Inc ,Hermes Inc ,Securities Exchange Commission ,Alnylam Pharmaceuticals Price Performance ,Alnylam Pharmaceuticals ,Norges Bank ,Nasdaq ,Goldman Sachs Group ,Partners Asset Management ,Free Report ,Management Group ,London Asset Management ,Federated Hermes ,Get Free Report ,Director Amy ,Visit Holdingschannel ,Alnylam Pharmaceuticals Daily ,